Peroxisome Proliferator-Activated Receptor-&agr; Activation Reduces Salt-Dependent Hypertension During Chronic Endothelin B Receptor Blockade

No abstract is available for this paper.

• Publication year

  2005

• Venue

  HYPERTENSION

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000172755.25382.fcPMID 15967866
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fenofibrate Prevents the Development of Angiotensin II–Dependent Hypertension in Mice

  2005cited by this paper
• ETA Receptor Blockade Attenuates Hypertension and Decreases Reactive Oxygen Species in ETB Receptor-Deficient Rats

  2004cited by this paper
• Elevated BSC-1 and ROMK Expression in Dahl Salt-Sensitive Rat Kidneys

  2004cited by this paper
• A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.

  2004cited by this paper
• Arterial Pressure Response to the Antioxidant Tempol and ETB Receptor Blockade in Rats on a High-Salt Diet

  2004cited by this paper
• Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis.

  2004cited by this paper
• Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.

  2003cited by this paper
• Endothelin.

  2003cited by this paper
• Functional Role of ETB Receptors in the Renal Medulla

  2003cited by this paper
• Inhibitors of 20-HETE Formation Promote Salt-Sensitive Hypertension in Rats

  2003cited by this paper
• Gender Differences in ET and NOS Systems in ETB Receptor-Deficient Rats: Effect of a High Salt Diet

  2003cited by this paper
• Molecular mechanisms of iNOS induction by IL-1 beta and IFN-gamma in rat aortic smooth muscle cells.

  2002cited by this paper
• Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule.

  2002cited by this paper
• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• Evidence for endothelin involvement in the response to high salt.

  2001cited by this paper
• Salt-sensitive hypertension in endothelin-B receptor-deficient rats.

  2000cited by this paper
• Signaling mechanisms regulating bombesin-mediated AP-1 gene induction in the human gastric cancer SIIA.

  2000cited by this paper
• Renal endothelin in hypertension.

  2000cited by this paper
• Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release.

  2000cited by this paper
• Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats.

  1999cited by this paper
• Renal functional effects of endothelins: dependency on cytochrome P450-derived arachidonate metabolites.

  1998cited by this paper
• Joint time and time-frequency optimal detection of K-complexes in sleep EEG.

  1998cited by this paper
• Effects of lipid-lowering agents in the Dahl salt-sensitive rat.

  1998cited by this paper
• Induction of P4504A activity improves pressure-natriuresis in Dahl S rats.

  1998cited by this paper
• The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na,K-ATPase and redistribution of apical NHE-3 during acute hypertension.

  1998cited by this paper
• Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats.

  1997cited by this paper
• Differential regulation of renal regional blood flow by endothelin-1.

  1996cited by this paper
• Synthesis and secretion of endothelin in a cortical collecting duct cell line.

  1996cited by this paper
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

  1996cited by this paper
• Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats.

  1996cited by this paper
• Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta.

  1996cited by this paper
• Prostaglandin E2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat.

  1995cited by this paper
• Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.

  1994cited by this paper
• Differential expression and activation of a family of murine peroxisome proliferator-activated receptors.

  1994cited by this paper
• Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD.

  1993cited by this paper
• Endothelins in the kidney: physiology and pathophysiology.

  1993cited by this paper
• Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.

  1993cited by this paper
• Production of endothelin-1 by rat mesangial cells: regulation by tumor necrosis factor.

  1992cited by this paper
• Regulation of endothelin-1 production in cultured rat mesangial cells.

  1992cited by this paper
• Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone.

  1992cited by this paper
• Characterization of endothelin 1 receptor and signal transduction mechanisms in rat medullary interstitial cells.

  1991cited by this paper
• Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle.

  1991cited by this paper
• Regulated expression of endothelin 1 in glomerular capillary endothelial cells.

  1991cited by this paper
• Endothelin synthesis by rabbit renal tubule cells.

  1991cited by this paper
• Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells.

  1989cited by this paper
• Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase

  1985cited by this paper

• New insights on association between circadian rhythm and lipid metabolism in spontaneously hypertensive rats.

  2021cites this paper
• Peroxisome proliferator-activated receptor-γ mediates the antihypertensive effects of acupuncture in spontaneously hypertensive rats

  2020cites this paper
• 14.03 – Renal Xenobiotic Metabolism☆

  2018cites this paper
• PPARα-dependent increase of mouse urine output by gemfibrozil and fenofibrate.

  2017cites this paper
• Peroxisome proliferator-activated receptors for hypertension.

  2014cites this paper
• PPARα ligand clofibrate ameliorates blood pressure and vascular reactivity in spontaneously hypertensive rats

  2014cites this paper
• Effects of CP-900691, A Novel Peroxisome Proliferator-Activated Receptor α Agonist on Diabetic Nephropathy in the BTBR ob/ob mouse

  2014cites this paper
• Peroxisome proliferator-activated receptors for hypertension World Journal of Cardiology

  2014cites this paper
• 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases.

  2013cites this paper
• Endothelin, kidney disease, and hypertension.

  2013cites this paper
• Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice

  2012cites this paper
• Molecular Pathways and Crosstalk Characterizing the Cardiorenal Syndrome

  2012cites this paper
• Relaxation of rat thoracic aorta by fibrate drugs correlates with their potency to disturb intracellular calcium of VSMCs.

  2012cites this paper
• Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension , Attenuates Plasma Interleukin-6 Levels and Renal InflammatoryMarkers in Angiotensin II InfusedMice

  2012cites this paper
• Age-related differences in the effects of α and γ peroxisome proliferator-activated receptor subtype agonists on endothelial vasodilation in human microvessels.

  2012cites this paper
• Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension

  2011cites this paper
• Role of 20-Hydroxyeicosatetraenoic Acid in Mediating Hypertension in Response to Chronic Renal Medullary Endothelin Type B Receptor Blockade

  2011cites this paper
• Contrasting effects of intervention with ETA and ETB receptor antagonists in hypertension induced by angiotensin II and high-salt diet.

  2010cites this paper
• Evidence of direct smooth muscle relaxant effects of the fibrate gemfibrozil.

  2010cites this paper
• Oral Intake of Rosiglitazone Promotes a Central Antihypertensive Effect Via Upregulation of Peroxisome Proliferator-Activated Receptor-&ggr; and Alleviation of Oxidative Stress in Rostral Ventrolateral Medulla of Spontaneously Hypertensive Rats

  2010cites this paper
• Renal Xenobiotic Metabolism

  2010cites this paper
• Peroxisome Proliferator–Activated Receptors and The Metabolic Syndrome

  2009cites this paper
• Effect of peroxisome proliferator-activated receptor-α siRNA on hypertension and renal injury in the rat following nitric oxide withdrawal and high salt diet

  2009cites this paper
• Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.

  2008cites this paper
• Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARα null mice

  2008cites this paper
• PPAR-Alpha Agonist Fenofibrate Induces Renal CYP Enzymes and Reduces Blood Pressure and Glomerular Hypertrophy in Zucker Diabetic Fatty Rats

  2008cites this paper
• Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension.

  2008cites this paper
• Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: are the reagents beneficial or harmful?

  2008cites this paper
• Clofibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension

  2008cites this paper
• Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.

  2008cites this paper
• PPAR Ligands: Are They Potential Agents for Cardiovascular Disorders?

  2007cites this paper
• Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.

  2007cites this paper
• Peroxisome proliferator-activated receptor alpha: friend or foe?

  2007cites this paper
• Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension

  2007cites this paper
• Nephrology beyond JASN

  2006cites this paper
• CHAPTER 175 – Renal Endothelin

  2006cites this paper
• Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–&agr; Activators: Clinical and Experimental Evidence

  2006cites this paper
• Lowering of Blood Pressure—The Lower, the Better? Patients with

  2006cites this paper
• Lowering of Blood Pressure—The Lower, the Better? Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884–893, 2006

  2006cites this paper
• More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation.

  2005cites this paper